Summary by Moomoo AI
Panbela Therapeutics, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1, with the file number 333-278403. The company seeks to have the registration become effective on April 15, 2024, at 5:30 p.m. Eastern Time, or as soon thereafter as possible. This request was made in accordance with Rule 461 under the Securities Act of 1933. Panbela Therapeutics acknowledges its responsibilities related to the proposed public offering of securities as detailed in the Registration Statement. Any inquiries or comments regarding this acceleration request are to be directed to the company's counsel, Joshua L. Colburn of Faegre Drinker Biddle & Reath LLP.